Medtronic receives CE Mark for updated MRI pacemaker

Justine Varieur Cadet | | Health Exec | Precision Medicine
Medtronic has received the European CE Mark for its second-generation pacemaker for use with MRI machines, the Advisa DR MRI SureScan pacing system.

The company said its Advisa MRI SureScan pacing system combines MRI SureScan with features from Medtronic pacemakers and defibrillator systems such as managed ventricular pacing, OptiVol fluid status monitoring and ventricular and atrial capture management (VCM and ACM).

VCM and ACM are intended to adjust impulses for optimal stimulation of the heart's chambers, according to the Minneapolis-based Medtronic.
]
The device also offers enhanced diagnostics to help assist physicians in the diagnosis of irregular heart rhythms, particularly atrial tachyarrhythmia/atrial fibrillation. Additionally, upon commercial release, the Advisa MRI SureScan pacing system will be available for remote follow-up via the Medtronic CareLink Network.

The Advisa MRI SureScan pacing system currently is not available for sale in the U.S.

Justine Varieur Cadet

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

AI in Healthcare
4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Design by Adaptive Theme
Trimed Popup
Trimed Popup